Aug 28th, 2019
Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says
John Thero, Amarin Corp. chief executive officer, discusses the company's plans for its cardiovascular drug Vascepa. He speaks with Bloomberg's David Westin on "Balance of Power." (Corrects drug name in graphic.) (Source: Bloomberg)
